Warfarin Sodium Tablets recalled over manufacturing violations
- Recall date
- January 26, 2022
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- CARDINAL HEALTHCARE recalls Warfarin Sodium Tablets, USP, 5 mg, 100 Tablets per bottle, Rx Only, Manufactured for: Teva Pharmaceuticals, Parsippany…
- Recall number
- D-0201-2024
- FDA classification
- Class II
- Brand / firm
- CARDINAL HEALTHCARE
- Sold / distributed
- Nationwide USA
Why it was recalled
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Warfarin Sodium Tablets, USP, 5 mg, 100 Tablets per bottle, Rx Only, Manufactured for: Teva Pharmaceuticals, Parsippany, NJ 07054. NDC: 0093-1721-01
Get recall alerts
Free email alert whenever CARDINAL HEALTHCARE has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: CARDINAL HEALTHCARE